Rosanna Tarricone

Professor Rosanna Tarricone is Associate Dean at SDA Bocconi School of Management and Associate Professor in Health Policy at Bocconi University, Department of Social and Political Science, Milan.
Her research focuses on health technology assessment (HTA), health policy, and the economic evaluation of health technologies, with particular interest in sustainability, access, and innovation in healthcare systems. She has contributed to advancing methodologies in economic evaluation, supported regulatory development for medical technologies, and explored the translation of evidence into policy and procurement decisions.

She has published extensively in international journals such as The Lancet, Health Economics, Social Science & Medicine, eBioMedicine, npj Digital Medicine, and Vaue in Health, addressing topics such as cost-effectiveness, HTA processes, evidence generation for medical technologies, and public health policy.

Professor Tarricone holds an MSc in Health Services Management and a PhD in Public Health and Policy from the London School of Hygiene and Tropical Medicine, University of London, after graduating in Management from Bocconi University.

She is Principal Investigator of HEU-EFS, a large, EU-funded, multi-annual research project aimed at developing a European Program for Early Feasibility Studies for medical devices. She serves as expert advisor to the European Commission’s DG Research and DG Health and contributes to several high-level policy initiatives, including the Steering Committee of the Italian National HTA Program for Medical Devices, the national Working Group on Telemedicine (AGENAS), the Parliamentary Group on Digital Health and Therapeutics, and the National Observatory on Antibiotic Resistance.
Between 2005 and 2010, she served as Director of Economic Affairs at MedTech Europe, where she co-founded the European Health Technology Institute for Socio-Economic Research in collaboration with Bocconi University, the London School of Economics, and TU Berlin.

Professor Tarricone has also been actively involved in the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), serving on its Board of Directors (2016–2018), chairing the Publications Management Advisory Board (2018–2019), and co-chairing the 2019 North America Conference in New Orleans.

She continues to contribute to European and international initiatives aimed at strengthening the role of evidence in the development, evaluation, and adoption of health technologies, with a focus on improving access, value, and impact across healthcare systems.